Coronavirus Update

As our nation deals with the unprecedented effects of coronavirus, impacts to public events, work routines, commerce, and general human interaction are occurring in ways we may never have imagined. Many of the events listed here have altered plans and we encourage you to visit their websites for the latest information. From our team at CSI to you, your families, friends, and coworkers, please accept our sincere wishes for good health, safety, and a resumption of activities as soon as possible. We will get through this together but in the meantime please know that we are still available to you, so please do not hesitate to reach out.

Loading Events
This event has passed.

With mounting cost pressures and increased demands for affordable, value-based treatment options, bio/pharmaceutical teams face an increasingly competitive market, for both specialty and non-specialty products. Increasingly, the industry must strategize to manage the most critical challenges associated with product and patient services. CBI’s 13th Hub and SPP Model Optimization provides executives with strategies for developing and integrating hub programs and other patient-centric services to ensure product access and maximize reimbursement.